Peptides vs Retinoids: Which Does More for Aging Skin?
Peptides and retinoids are two of the most prominent categories in clinical skincare for aging. Both are legitimately evidence-backed. Both target collagen and skin structure. The question of which is "better" is less useful than understanding what each does and why the combination outperforms either alone.
The case for retinoids
Prescription tretinoin has the strongest evidence base of any topical ingredient for structural skin change. The mechanisms are well characterised:
Fibroblast stimulation. Tretinoin binds to retinoic acid receptors (RARs) in fibroblasts — the cells that produce collagen — and directly upregulates collagen gene expression. This is a primary mechanism, not an indirect effect.
MMP inhibition. Matrix metalloproteinases break down collagen. UV exposure significantly upregulates MMPs. Tretinoin downregulates MMP activity, slowing collagen degradation while new collagen is synthesised.
Epidermal renewal. Tretinoin accelerates the rate at which epidermal cells turn over, producing thicker, more renewed epidermis with better barrier function and reflectivity.
The evidence base spans over 40 years and includes randomised controlled trials showing measurable increases in dermal collagen density, improved skin thickness, and reduced photoaging severity with consistent tretinoin use.
The Core Formula is built on prescription tretinoin — the foundation of any serious skin longevity approach. Read more about why skin longevity starts with prescription retinoids.
The case for peptides
Signal peptides (matrikines) work through a different mechanism: they mimic the collagen breakdown fragments that naturally signal fibroblasts to produce more collagen. The best-studied — palmitoyl pentapeptide-4 (Matrixyl), palmitoyl tripeptide-1, palmitoyl tetrapeptide-7 — have clinical evidence for:
Increased collagen I, III, and IV production
Increased hyaluronic acid synthesis
Reduction in fine line depth over 4–8 weeks of consistent use
Copper peptides (GHK-Cu) have evidence for wound healing support, collagen synthesis, and antioxidant activity.
The evidence base for peptides is smaller than for tretinoin, and effect sizes are more modest. But the mechanisms are genuine — peptides work through signalling pathways that are independent of the retinoic acid receptor pathway that tretinoin uses.
Why they're better together
This is the key point that gets lost in "peptides vs retinoids" comparisons:
Tretinoin and signal peptides stimulate collagen through different receptor pathways. They're not redundant — they're additive. A formula combining tretinoin with palmitoyl peptides is stimulating fibroblasts through two independent mechanisms simultaneously, producing more collagen synthesis than either alone.
The clinical model at Laevo is building toward exactly this — compounded formulas that combine the proven prescription retinoid foundation with evidence-based peptides at clinically relevant concentrations. The compounding approach allows ingredient combinations and concentrations that commercial products don't offer. Read more about how compounding pharmacy skincare works and why it enables more sophisticated formulation.
The practical recommendation
If you're choosing between starting with peptides or starting with a prescription retinoid for skin longevity:
Start with the prescription retinoid. Tretinoin has the stronger, longer evidence base and produces the most meaningful structural change. It's the foundation.
Add peptides as a complement. Once the retinoid protocol is established and tolerated, peptide-rich formulations — either in the formula or alongside it — provide additive collagen-support benefit through complementary pathways.
This is not peptides vs retinoids. It's peptides with retinoids — which is categorically better than either alone.
Assessment fee applies. Prescription required — not all applicants will be approved. Individual results vary. This article is for informational purposes only and does not constitute medical advice.
